Cargando…
Treatments for atopic dermatitis
Atopic dermatitis usually develops in childhood, but can occur in adults. Management involves drug and non-drug treatments to clear the skin. Not all patients with atopic dermatitis have allergies. Most patients have trigger factors that can be avoided. All patients should use soap substitutes and b...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Therapeutic Guidelines
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664093/ http://dx.doi.org/10.18773/austprescr.2023.002 |
_version_ | 1785148698490044416 |
---|---|
author | Ross, Gayle |
author_facet | Ross, Gayle |
author_sort | Ross, Gayle |
collection | PubMed |
description | Atopic dermatitis usually develops in childhood, but can occur in adults. Management involves drug and non-drug treatments to clear the skin. Not all patients with atopic dermatitis have allergies. Most patients have trigger factors that can be avoided. All patients should use soap substitutes and bath oils. Moisturisers are important for improving the condition of the skin. Topical corticosteroids are the main drug treatment. The choice of corticosteroid depends largely on the site of the atopic dermatitis. Topical calcineurin inhibitors can be considered for sensitive sites such as the face where potent topical corticosteroids are potentially harmful. Adjunctive treatments given during flares of dermatitis include bleach baths and wet dressings. Antihistamines may help to relieve itch. Phototherapy may be considered by a specialist for adults if there is inadequate response to treatment. Severe cases of atopic dermatitis may require systemic treatment. Immunosuppressants, such as ciclosporin, have been used and now dupilumab and upadacitinib are available for severe chronic atopic dermatitis. |
format | Online Article Text |
id | pubmed-10664093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Therapeutic Guidelines |
record_format | MEDLINE/PubMed |
spelling | pubmed-106640932023-12-05 Treatments for atopic dermatitis Ross, Gayle Aust Prescr Article Atopic dermatitis usually develops in childhood, but can occur in adults. Management involves drug and non-drug treatments to clear the skin. Not all patients with atopic dermatitis have allergies. Most patients have trigger factors that can be avoided. All patients should use soap substitutes and bath oils. Moisturisers are important for improving the condition of the skin. Topical corticosteroids are the main drug treatment. The choice of corticosteroid depends largely on the site of the atopic dermatitis. Topical calcineurin inhibitors can be considered for sensitive sites such as the face where potent topical corticosteroids are potentially harmful. Adjunctive treatments given during flares of dermatitis include bleach baths and wet dressings. Antihistamines may help to relieve itch. Phototherapy may be considered by a specialist for adults if there is inadequate response to treatment. Severe cases of atopic dermatitis may require systemic treatment. Immunosuppressants, such as ciclosporin, have been used and now dupilumab and upadacitinib are available for severe chronic atopic dermatitis. Therapeutic Guidelines 2023-06-22 2023-06 /pmc/articles/PMC10664093/ http://dx.doi.org/10.18773/austprescr.2023.002 Text en (c) Therapeutic Guidelines https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Article Ross, Gayle Treatments for atopic dermatitis |
title | Treatments for atopic dermatitis |
title_full | Treatments for atopic dermatitis |
title_fullStr | Treatments for atopic dermatitis |
title_full_unstemmed | Treatments for atopic dermatitis |
title_short | Treatments for atopic dermatitis |
title_sort | treatments for atopic dermatitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664093/ http://dx.doi.org/10.18773/austprescr.2023.002 |
work_keys_str_mv | AT rossgayle treatmentsforatopicdermatitis |